Zogenix’ drug cuts seizures in Dravet syndrome
Zogenix has revealed top-line results from a second late-stage trial of its investigational Dravet syndrome drug ZX008, showing a significant reduction in seizures.
12th July 2018
Latest news
NHS under ‘intolerable’ strain
NHS Confederation chief executive Niall Dickson is warning that the NHS is “under intolerable strain”, after the latest performance data continue to show growing demand and missed targets.
12th July 2018
Roche’s Venclexta filed in the US for acute myeloid leukemia
Roche group Genentech has filed an application to market Venclexta in the US for acute myeloid leukemia (AML).
12th July 2018
NICE backs Qarziba for children with high-risk neuroblastoma
NHS funding for EUSA’s Pharma’s Qarziba has been approved to treat children with high-risk neuroblastoma.
12th July 2018
AbbVie, J&J’s Imbruvica fails to target in B-Cell lymphoma trial
AbbVie and Johnson & Johnson’s Imbruvica has failed to meet its key target in a late stage study assessing its use in patients with treatment-naïve diffuse large B-cell lymphoma.
12th July 2018
Pfizer re-organises into three business units
Pfizer has announced a re-organisation of its operations into three distinct businesses.
12th July 2018
NICE backs use of dye for brain tumour removal
NICE has published new guidelines recommending use of a chemical dye to assist neurosurgeons in removing brain tumours.
11th July 2018
NHS England appoints national clinical advisor for primary care
NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.
11th July 2018
Janssen launches PhII/III programme testing Tremfya in Crohn’s
Janssen has kicked off a Phase II/III programme assessing Tremfya in Crohn's Disease.
11th July 2018
Gov’t launches £10 antimicrobial research competition
The government has launched a £10 million research competition to encourage the development of novel approaches to combating antimicrobial resistance and improving infection prevention and control.
11th July 2018
Takeda gets US nod for Shire buy
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.
10th July 2018
NICE advises restricted use of antibiotics for COPD
The National Institute for Health and Care Excellence is advising healthcare professionals to restrict use of antibiotics for chronic obstructive pulmonary disease (COPD).
10th July 2018
CTI, Servier’s Pixuvri fails in post-marketing trial
A late-stage trial of Servier and CTI BioPharma’s Pixuvri in combination with Roche's MabThera has failed to hit targets in B-cell non-Hodgkin lymphoma, putting its conditional approval in Europe in jeopardy.
10th July 2018
Three cancer treatments approved for use on NHS Scotland
Three treatments have been approved for NHS funding in Scotland, bringing new options for gastroenteropancreatic tumours, lung and kidney cancers, but patients with multiple sclerosis will be unable to access Roche’s Ocrevus following a rejection by the SMC.
10th July 2018
May names Hancock as new health and social care secretary
Prime Minister Theresa May has named West Suffolk MP Matt Hancock as the new secretary of state for health and social care.
10th July 2018
